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Abstract
Background: NAD
+ is a coenzyme for hydride transfer enzymes and a substrate for sirtuins and other NAD
+-dependent ADPribose transfer enzymes. In wild-type Saccharomyces cerevisiae, calorie restriction accomplished by
glucose limitation extends replicative lifespan in a manner that depends on Sir2 and the NAD
+ salvage enzymes,
nicotinic acid phosphoribosyl transferase and nicotinamidase. Though alterations in the NAD
+ to nicotinamide ratio
and the NAD
+ to NADH ratio are anticipated by models to account for the effects of calorie restriction, the nature of
a putative change in NAD
+ metabolism requires analytical definition and quantification of the key metabolites.
Results: Hydrophilic interaction chromatography followed by tandem electrospray mass spectrometry were used
to identify the 12 compounds that constitute the core NAD
+ metabolome and 6 related nucleosides and
nucleotides. Whereas yeast extract and nicotinic acid increase net NAD
+ synthesis in a manner that can account for
extended lifespan, glucose restriction does not alter NAD
+ or nicotinamide levels in ways that would increase Sir2
activity.
Conclusions: The results constrain the possible mechanisms by which calorie restriction may regulate Sir2 and
suggest that provision of vitamins and calorie restriction extend lifespan by different mechanisms.
Background
The pyridine dinucleotide, NAD
+, synthesized from the
pyridine mononucleotides nicotinic acid mononucleotide
(NaMN) or nicotinamide mononucleotide (NMN), is a
unique cellular molecule that cycles between NAD
+ and
NADH co-enzymatically and is cleaved to produce nico-
tinamide (Nam) and acetylated ADPribose in protein
lysine deacetylation by sirtuins [1]. Typically, eukaryotic
de novo biosynthetic pathways produce NaMN from
tryptophan through quinolinic acid (QA) and from the
vitamin, nicotinic acid (NA). Eukaryotic salvage pathways
produce NMN from Nam and/or nicotinamide riboside
(NR) [2,3]. The biosynthetic pathways for NAD
+ in Sac-
charomyces cerevisiae are schematized in Figure 1.
Though most eukaryotic NAD
+ biosynthetic pathways
were described long ago, we have only recently deter-
mined the gene and enzyme basis for the NR kinase
pathway [4], NR kinase-independent NR salvage [5,6],
specific NR transport [7], specific utilization of nicotinic
acid riboside (NAR) [8,9], and dephosphorylation of
NMN and NaMN to NR and NAR [10].
Several lines of reasoning indicate that the availability
of salvageable vitamin precursors and the regulation of
salvage enzymes are key determinants of Sir2 function.
First, the NA salvage enzyme nicotinic acid phosphori-
bosyl transferase, Npt1, is required for the longevity
benefit of calorie restriction (CR) [11]. Second, the Nam
salvage enzyme nicotinamidase, Pnc1, is induced by CR
and other stresses and its induction correlates with
increased lifespan [12]. Third, yeast cells grown without
NA or NR are fully viable but have a short replicative
lifespan [5]. Fourth, provision of NR extends lifespan in
a manner that depends on NR salvage enzymes, Nrk1,
Urh1 and Pnp1 [5]. However, there have been funda-
mental critiques of the body of work that has attributed
the longevity benefit of CR to Sir2. In particular, lifespan
extension independent of Sir2 has been demonstrated
and a Sir2-independent target of nicotinamide has been
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exhibits increased gene silencing activity upon CR [14]
appears to be artifactual [15,16]. Though Sir2 may not
increase gene silencing upon CR, it appears that CR
results in reduced ribosomal DNA recombination via a
mechanism involving reduced Tor signaling [15,17] and/
or the association of Sir2 with ribosomal genes at the
inner nuclear membrane [16,18].
Several models have been developed to account for
how NAD
+ metabolism might be regulated by CR in a
manner that would increase Sir2 localization and/or
function. According to one model, CR lowers Nam
levels, thereby relieving Sir2 inhibition [12]. A second
model claims that CR lowers NADH levels, thereby
relieving Sir2 competitive inhibition [19]. Our prior
work indicates that increased net NAD
+ synthesis in the
presence of salvageable vitamins accounts for increased
Sir2 function [5], though we had not determined
whether NAD
+ metabolites are altered by CR. Moreover,
our recent work indicates that Isn1, which encodes an
IMP, NMN and NaMN 5’-nucleotidase activity, is
increased in expression by provision of glucose and
nicotinic acid [10]. Here, to dissect the basis for longer
lifespan in vitamin-replete versus vitamin-free medium
and to determine whether NAD
+ metabolism is altered
by CR, we developed a liquid chromatrography mass
spectrometry (LC-MS) method to analyze the yeast NAD
+ metabolome. The method, utilizing electrospray ioniza-
tion (ESI) and selected reaction monitoring (SRM), is
powerful and sensitive, providing detection of all metabo-
lites, including the predicted metabolites, NAR and NR.
The data indicate that increased net NAD
+ synthesis in
rich and vitamin-replete medium may explain increased
lifespan with respect to vitamin-free medium. However,
the data are largely inconsistent with levels or ratios of
NAD
+, Nam or NADH as mediators of the effect of glu-
cose limitation on lifespan, suggesting that provision of
vitamins and CR extend lifespan by different mechan-
isms. Moreover, the levels of NaMN and NMN are suffi-
cient to allow regulated expression of NaMN/NMN
adenylyltransferases and NaMN/NMN 5’ nucleotidases
[10] to push NAD
+ metabolism forward to NaAD and
NAD
+ or backward to NAR and NR.
Results and Discussion
Identification of the core NAD+ metabolome in extracts
of ml cultures of yeast
Recently, Tsuchiya and co-workers reported an LC-MS
method with partial coverage of the NAD
+ metabolome.
Levels of NAD
+,N M N ,N a M N ,A D P r i b o s ea n dA M P
were reported in mouse erythrocytes. However, NADH,
N A D P ,N A D P H ,Q A ,N R ,N A R ,N A ,N a m ,a n d
Figure 1 De novo synthesis begins with tryptophan, which is converted to NaMN in six enzymatic steps. NaMN is then adenylylated by
Nma1 and Nma2 to NaAD, which is converted to NAD
+ by glutamine-dependent NAD
+ synthetase, Qns1. NaMN is also formed by salvage of
Nam, via nicotinamidase, Pnc1, and nicotinic acid phosphoribosyltransferase, Npt1. Environmental NA also generates NaMN via the
phosphoribosylation activity of Npt1. NR is converted to NMN via Nrk1, then to NAD
+ by Nma1 and Nma2. Additionally, NAR can utilize Nrk1-
dependent phosphorylation and both NR and NAR can be converted to NAD
+ in Nrk1-independent pathways initiated by nucleoside splitting
activities. The nucleosides NR and NAR are produced intracellularly by the 5’-nucleotidase activities of Sdt1 and Isn1 acting on NMN and NAR.
NAD
+ is broken down by the sirtuins, Sir2 and Hst1-4.
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Page 2 of 10nicotinic acid adenine dinucleotide (NaAD) were unde-
tected or below detection limits in the biological sample
[20]. Lu and co-workers detected NAR and NR in yeast
extracts by LC-MS but determined NAD
+ levels using a
cycling assay [21]. Here, the core NAD
+ metabolome
was detected and quantified by LC-MS using 1% of the
yeast cell number of the previous method. Keys to the
present method were HILIC on an aminopropyl station-
ary phase at basic pH, positive ion mode SRM detection
of 17 compounds, and negative ion mode detection of
QA. Separation and fragmentation behaviors of the
18 compounds are shown in Figure 2. As shown in
Table 1, the limits of quantification (LOQ) for 18
metabolites were in a 20-fold range from 0.06 pmol
(NAR and NADH) to 1.2 pmol (NA and Urd). Technical
replication errors measured in relative standard devia-
tion (RSD) were 10% or less for 16 of 18 compounds.
To determine whether metabolite standards are stable
in extraction conditions, triplicate mixtures of authentic
NAD metabolite standards were placed into to 0.3 mL
of boiling buffered ethanol and maintained at 80°C for 3
minutes. For comparison, identical mixtures of NAD
metabolite standards were combined with 0.3 mL cold
buffered ethanol and were maintained on ice. Both
groups of samples were dried by Speedvac and reconsti-
tuted in 80% methanol/20% water, and were then
Figure 2 Chromatograms of 18 NAD
+-related compounds generated using SRM LC-MS. All compounds except quinolinic acid were
detected using positive ion mode. Injected amount was 10 pmol for all compounds.
Evans et al. BMC Chemical Biology 2010, 10:2
http://www.biomedcentral.com/1472-6769/10/2
Page 3 of 10analyzed by LC-MS. For all metabolites, average
decreases in metabolite peak area from exposure to boil-
ing extraction solvent were determined to be 15% or
less. The observed decreases were not found to be sta-
tistically significant for any compound except inosine,
which showed a 13.9% decrease (p = 0.04). These data
are shown in Additional file 1, Table S1.
To validate the quantitative accuracy of the method, it
was necessary to determine whether ionization suppres-
sion and other matrix effects might affect the validity of
metabolite calibration curves in the presence of cellular
extracts. To develop an extract nearly devoid of the
metabolites in question, an isotopically labeled yeast
extract was prepared by growing Fleischmann’s yeast on
medium containing uniformly
13C-labeled glucose (97%).
The
13C yeast cultures were harvested at the same opti-
cal density as the unlabeled yeast cultures, and metabo-
lites were extracted from
13C-labeled yeast using the
boiling buffered ethanol procedure [22]. The extract was
then spiked with 5 μM
12C authentic NAD metabolite
standards and analyzed using LC-MS/MS.
To assess ionization suppression, the peak areas for
the
12C standards in the
13C yeast extract were com-
pared to the peak areas for a pure
12C standard mixture.
These data are shown in Additional file 1, Table S2. All
but three of the compounds showed no to moderate
(<30%) reduction in signal in the presence of
13C yeast
extract. Thus, for the majority of the components of the
NAD
+ metabolome, the method is sufficiently free from
ionization suppression to allow direct quantification of
the components of the NAD
+ metabolome in biological
extracts. The three compounds that showed a more
severe reduction of signal in the
13C yeast extract were
NAD
+ (49% attenuation of signal), Ino (70% attenua-
tion), and NA (76% attenuation). For these compounds,
determination of absolute concentrations of the metabo-
lites in cell extracts is subject to larger errors, although
relative quantification is still possible. More robust
quantification could be achieved with isotopically
labeled internal standards for those components of the
NAD
+ metabolome prone to ionization suppression, or
by inclusion of a global internal standard, such as an
isotopically labeled extract, in all samples.
Increased net NAD+ biosynthesis in rich and vitamin-
supplemented media
Yeast cells are either grown in rich medium, containing
yeast extract, or in synthetic medium, which contains
salts, metals, specific amino acids and nucleobases, and
a selection of vitamins [23]. Because yeast nitrogen base
was formulated to support the growth of every yeast
species [24] including Candida glabrata, which has no
de novo biosynthetic capacity [25], synthetic yeast med-
ium typically contains 3 μM NA. NA-free synthetic
medium supports the growth of wild-type S. cerevisiae
but the replicative lifespan on such medium is approxi-
mately half that of cells grown on SDC with NA, SDC
w i t hN Ro ro nY P D[ 5 ] .E a r l i e r ,w er e p o r t e dt h a ty e a s t
cells grown on SDC with NA have an intracellular NAD
+
concentration of ~2 mM, which declines to about 1 mM
as cells reach stationary phase, that yeast cells grown
on vitamin-free SDC have an intracellular NAD
+
Table 1 LC-MS/MS SRM parameters and sensitivity details for NAD
+ metabolites and related nucleosides and
nucleotides
Metabolite Parent mass Product mass Cone voltage Collision Energy RT (min) LOQ (pmol) R
2 RSD (%)
Nam 123 80 35 20 3.68 0.45 0.996 7
NA 124 80 35 20 7.15 1.20 0.999 12
Cyt 244 112 35 10 4.52 0.10 0.995 10
Urd 245 113 90 10 4.56 1.20 0.978 10
NR 255 123 50 10 4.07 0.20 0.992 7
NAR 256 124 35 10 4.80 0.06 0.984 5
Ino 269 137 80 10 6.31 0.07 0.993 3
CMP 324 112 35 10 12.05 0.68 0.999 6
UMP 325 97 90 15 12.22 0.21 0.989 8
NMN 335 123 35 10 9.04 0.50 0.988 9
QA 166 (-) 122 35 10 12.34 9
NaMN 336 124 35 10 11.66 0.18 0.999 5
IMP 349 137 80 10 13.59 0.13 0.997 5
NAD
+ 664 542 35 18 8.69 0.17 0.996 8
NaAD 665 542 35 20 11.59 0.26 0.987 8
NADH 666 649 35 20 11.77 0.06 0.991 16
NADP 744 604 35 25 14.01 0.87 0.995 9
NADPH 746 729 35 20 16.18 0.17 0.994 8
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SDC with 10 μM NR in place of NA have a stable intra-
cellular NAD
+ concentration of ~2 mM. To test whether
the LC-MS method could detect two-fold differences in
NAD
+ levels and to determine whether other metabolites
are altered by medium components other than glucose,
we subjected cells grown in YPD, SDC and SDC without
NA to extraction and metabolite analysis by LC-MS. As
shown in Table 2, the availability of yeast extract and NA
clearly increases net NAD
+ synthesis by two-fold into the
NAD
+ and NADH pools, consistent with the increased
Sir2 functions and replicative longevity of cells grown in
such conditions [5].
Because prior investigations of the effect of NA, NR
and NAR only examined accumulation of NAD
+ [5,8], it
was interesting to examine how provision of NA or
yeast extract and peptone (i.e., YPD) might alter the
NAD
+ metabolome as a whole. As shown in Table 2,
NAD
+ metabolites fall into several categories with
respect to provision of NA and yeast extract. Whereas
NAD
+ and NADH increase approximately two-fold with
either life-extending change in medium, NADP and
NADPH are little changed. In contrast, the intracellular
levels of NR and NMN were increased 2-4 fold, NaMN
4-10 fold, and Nam and NAR increased >20-fold by
both life-extending conditions. These data suggest that
not only is net NAD
+ synthesis increased by medium
components, but that NAD
+ anabolic and catabolic pro-
cesses are quantitatively and/or qualitatively altered by
provision of medium components.
In addition to NAD
+ metabolites, we measured three
nucleosides (Urd, Cyt and Ino) and three nucleoside
monophosphates (UMP, CMP and IMP). Each nucleo-
side was strikingly increased in rich medium, suggesting
that these nucleosides are present in yeast extract. Not
surprisingly, the corresponding nucleoside monopho-
sphates were also greatly increased by provision of rich
medium. For unknown reasons, NA increased the net
synthesis of UMP by more than two-fold.
Glucose limitation only mildly alters levels
of NAD+ metabolites
In mouse liver, a one day fast has been reported to ele-
vate NAD
+ levels [26]. Similarly, CR has been reported
to elevate NAD
+ levels in brain [27]. This could either
be mediated by increased net NAD
+ biosynthesis in
these tissues or by increased mobilization of tryptophan
or vitamin precursors of NAD
+ [2]. To test whether
yeast cells have a cell-autonomous mechanism to alter
NAD
+ levels, we grew wild-type yeast cells in SDC
media differing in glucose concentration (2%, 0.5% and
0.2%). Extraction and LC-MS analysis of these samples
revealed the apparent intracellular metabolite concentra-
tions shown in Table 2. The results are rather striking
for the constancy in metabolite levels as a function of
glucose limitation. Excluding NA and NaAD, which
were not consistently detected in yeast samples, and
NADPH, which was present at <1 μMi nt h eY P Ds a m -
ple, no compound was increased or decreased two-fold
by glucose limitation to both 0.5% and 0.2%.
Table 2 Intracellular micromolar concentrations of NAD
+ metabolites and related nucleosides and nucleotides as a
function of medium components
Metabolite SDC-NA SDC YPD YPD0.5 YPD0.2
Nam 1.5 ± 0.2*† 31.6 ± 3.0 35.0 ± 3.2 29.7 ± 0.3 51.9 ± 17.9
NA <0.5 <0.5 <0.5 <0.5 <0.5
Cyt 1.8 ± 0.2† 1.5 ± 0.2† 69.5 ± 11.5 42.2 ± 9.1 63.4 ± 13.5
Urd 5.3 ± 1.4† 13.0 ± 3.0† 139.7 ± 0.6 141.7 ± 0.2 128.7 ± 7.0
NR 2.1 ± 0.3*† 4.6 ± 0.9† 9.3 ± 0.4 7.9 ± 1.5 7.1 ± 1.4
NAR 0.2 ± 0.0*† 8.1 ± 1.3 12.5 ± 0.2 8.3 ± 1.7 8.4 ± 0.7†
Ino 21.8 ± 1.7*† 6.0 ± 0.4† 54.9 ± 2.6 38.5 ± 3.3† 31.8 ± 3.3†
CMP 31.5 ± 1.5 39.7 ± 9.1 146.4 ± 16.7 134.8 ± 45.1 165.3 ± 38.3
UMP 63.0 ± 7.0*† 145.4 ± 27.9 179.6 ± 2.7 238.0 ± 20.9 236.6 ± 23.2
NMN 19.0 ± 1.9*† 67.3 ± 13.0 62.1 ± 13.7 60.0 ± 14.8 72.4 ± 21.2
NaMN 2.9 ± 0.2*† 28.0 ± 4.5 11.6 ± 2.0 18.4 ± 4.3 21.1 ± 3.7
IMP 8.4 ± 0.3 7.1 ± 1.8 16.8 ± 6.3 16.1 ± 1.5 16.1 ± 1.5
NAD
+ 277.2 ± 26.7* 513.9 ± 51.1 438.5 ± 66.7 308.9 ± 33.8 339.5 ± 11.7
NaAD <0.1 <0.1† 3.8 ± 0.3 <0.1† <0.1†
NADH 125.8 ± 13.6*† 207.3 ± 17.1 263.0 ± 55.3 101.2 ± 24.6 152.0 ± 12.7
NADP 31.2 ± 1.4 31.1 ± 3.5 46.9 ± 10.2 42.9 ± 7.2 52.5 ± 2.1
NADPH 0.3 ± 0.1* 3.1 ± 0.6 0.7 ± 0.2 1.3 ± 0.1 3.0 ± 0.2†‡
* indicates a significant difference when compared to cells grown in SDC. † indicates a significant difference when compared to cells grown in YPD. ‡ indicates a
significant difference between cells grown in YPD 0.5 and YPD 0.2% glucose.
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present in SDC and YPD samples at ~30 μMa n dc a n
be detected in SDC -NA samples at 5% of this concen-
tration, was not reduced by glucose limitation. NAD
+,
which was increased by provision of NA or rich medium
(life-extending conditions), was moderately reduced by
glucose limitation, also a life-extending condition.
NADH, which was increased by provision of NA and by
rich medium, was reduced somewhat more than was
NAD
+. With glucose limitation to 0.5%, NADH was
reduced 2.6-fold. With glucose limitation to 0.2%,
NADH was reduced 1.7-fold. In contrast, the apparent
levels of NADPH were increased two-fold and four-fold
by glucose limitation to 0.5% and 0.2%, respectively,
though the absolute contribution of the NADPH frac-
tion of pyridine dinucleotides remained very small. Such
data suggest the possibility that an NADPH-generating
process may be positively regulated by CR, though the
target or the significance of elevated NADPH in replica-
tive longevity is unknown.
Levels and ratios of NAD+ metabolites
The present study indicates that yeast cells increase net
NAD
+ biosynthesis with additions of yeast extract and
NAD
+ precursor vitamins to the medium. Our previous
work suggests that yeast cells relying on de novo NAD
+
biosynthesis have an intracellular NAD
+ concentration
of ~1 mM that satisfies vital requirements but provides
little support for Sir2 function. According to these data,
intracellular NAD
+ concentrations above ~1 mM are
associated with longer replicative lifespan and cellular
NAD
+ concentrations vary from ~1 mM to ~2 mM [5].
By LC-MS, the NAD
+ concentration is ~0.28 mM in
vitamin-free medium and twice that when cells are
grown with NA. The lower NAD
+ concentrations in
LC-MS measurements are likely a result of ion
suppression.
With the caveat that ionization suppression reduced
the observed levels of NAD
+ more than NADP, NADH
a n dN A D P H ,i ti sp o s s i b l et ou s et h eN A D
+ metabolo-
mic data collected herein to compare the ratios of the
four major co-enzymatic forms of NAD
+ and determine
whether such ratios are altered by medium components
including NA and glucose. As shown in Table 3, NADH
as a proportion of NAD
+ is higher for cells grown in
YPD than in the other conditions. Consistent with a
model of CR that glucose limitation would create a
more oxidizing environment with a higher NAD
+:
NADH ratio [19], cells grown in 0.5% glucose had a
higher NAD
+:NADH ratio than cells grown in 2% glu-
cose. However, because NADH is such a poor inhibitor
of Sir2 (Ki ~ 17 mM) [29], it is not clear how reducing
NADH concentrations from ~0.26 mM to the 0.10 to
0.15 mM range would increase Sir2 activity. Similarly, it
remains to be seen if the increased NADPH as a pro-
portion of NAD
+, which correlated with glucose limita-
tion, is functionally related to the longevity-promoting
effects of CR.
Nam is a known product inhibitor of sirtuins [28] and
Pnc1, encoding nicotinamidase, is induced by CR condi-
tions and required for the longevity benefit of CR [12].
Thus, the proposed ability of CR to reduce cellular Nam
concentrations or increase the NAD
+:Nam ratio has
been an appealing model [12]. However, as shown in
Table 2 and Table 4, CR does not reduce Nam concen-
trations. Consistent with data obtained by
13CN M R
[30], NAD
+ is actually reduced by CR conditions. Thus,
as illustrated in Table 4, the ratio of NAD
+ to Nam is
uncorrelated with increased lifespan. Vitamin-free syn-
thetic medium, which provides the shortest lifespan, had
the highest NAD
+:Nam ratio and reduction of glucose
from rich medium reduced the NAD
+:Nam ratio further.
The levels of the pyridine mononucleotides NaMN
and NMN as compared to the levels of the dinucleotides
NaAD and NAD
+ are of interest in two respects. First,
the human NaMN/NMN adenylyltransferases are differ-
entially expressed and localized, suggesting that the ade-
nylylation steps in NAD
+ synthesis may be points of
regulation [31,32]. Second, with our recent discovery of
NR as a vitamin and both NR and NAR as apparent
yeast metabolites [4,5,8,9], we considered that produc-
tion of these two nucleosides might be controlled by 5’
nucleotidase activities acting on NMN and NaMN and
identified Isn1 and Sdt1 as multifunctional 5’-nucleoti-
dases that are responsible for cellular generation of NR
and NAR [10]. For the adenylylation steps in NAD
+ bio-
synthesis to be regulated and for production of NR and
NAR from NMN and NaMN to be plausible, cells
Table 3 Ratios of key metabolites: dinucleotide
subprofile
NADH NAD
+ NADP NADPH
SDC NA 0.45 1.0 0.11 0.001
SDC 0.40 1.0 0.06 0.006
YPD 0.60 1.0 0.11 0.002
YPD 0.5 0.33 1.0 0.14 0.004
YPD 0.2 0.45 1.0 0.15 0.009
Table 4 Ratios of key metabolites: Nam and NAD
+
subprofile
NAD
+ Nam
SDC -NA 184. 1.0
SDC 16.3 1.0
YPD 12.5 1.0
YPD 0.5 10.4 1.0
YPD 0.2 6.5 1.0
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pyridine mononucleotides. Though the NaMN/NMN
adenylyltransferases are known to perform reversible
reactions in vitro [33], such reactions, which produce
inorganic pyrophosphate, would be rendered irreversibly
forward in the direction of dinucleotides if the pyropho-
sphate is always rapidly consumed to orthophosphate in
vivo. Though pyrophosphate consumption is dogma,
actual measurements of pyrophosphate in budding yeast
cells indicate that levels can range from 10-1000 times
higher that ATP under various growth conditions [34].
As shown in Table 5, there was 7-21% as much NMN
to NAD
+ under all conditions examined. Thus, steady
state levels of the substrates of NaMN/NMN adenylyl-
transferases were detected under all conditions mea-
sured. In contrast, NaAD, the product of NaMN
adenylylation and the substrate of glutamine-dependent
NAD
+ synthetase Qns1 [35], was below 1% of the level
of NAD
+ under all conditions examined, suggesting that
NaAD produced from the de novo or Preiss-Handler
pathways is driven forward under kcat/Km conditions for
Qns1 [36].
Only a few years ago, NMN and NR were not
depicted on the metabolic schemes for how yeast cells
make NAD
+ [12,29,37-39]. As shown in Table 6, NMN
is more abundant than NaMN under all conditions
examined even though no condition investigated the
provision of NR, such that all NAD
+ biosynthesis is pro-
ceeding through NaMN. Moreover, just as the propor-
tion of NMN to NAD
+ suggested that NMN
adenylyltransferase is not running irreversibly forward,
the proportion of NR and NAR nucleosides to the cor-
responding NMN and NaMN nucleotides, shown in
Table 3D, suggests mechanisms by which the cell may
maintain nucleoside pools. Indeed, we have now identi-
fied Isn1, previously reported to be an IMP-specific 5’-
nucleotidase [40], and Sdt1, previously reported to be a
pyrimidine-specific 5’-nucleotidase [41], as responsible
for NR and NAR production in vivo [10].
Conclusions
The five growth conditions in this study allow two long-
evity-promoting regimens to be compared metabolically.
Cells grown with yeast extract or nicotinic acid have a
longer lifespan than cells grown in vitamin-free syn-
thetic media [5] and cells grown in reduced glucose
h a v eal o n g e rl i f e s p a nt h a nc e l l sg r o w ni n2 %g l u c o s e
[11]. Eight metabolites (Nam, NR, NAR, UMP, NMN,
NaMN, NAD
+ and NADH) are statistically significantly
higher in both SDC and YPD than in SDC -NA. How-
ever, none of these metabolites are higher in both 0.5%
and 0.2% glucose than in 2% glucose. Five metabolites
are lower in both CR conditions (NAR, Ino, NAD
+,
NaAD and NADH). Strikingly, three of the compounds
that rise with provision of vitamins (NAR, NAD
+ and
NADH) fall in CR conditions. These data suggest that
provision of vitamins and CR alter NAD
+ metabolism in
two different ways and that vitamins increase net NAD
+
synthesis in a manner that extends lifespan, whereas CR
employs a different mechanism.
The early models of CR either invoked increased flux
[42] or simple regulation of a single key Sir2-inhibitory
metabolite [19,30]. Though flux has not yet been investi-
gated and the data are inconsistent with simple regula-
tion of NAD
+,N A D Ho rN a m ,i tr e m a i n st ob e
determined whether the NAD
+ metabolite profile is
regulated in a complex manner by CR in a manner that
determines Sir2 biological activity or whether the meta-
bolic effects of CR are largely mediated in a Sir2-inde-
pendent manner. Models that depend on increased flux
will almost certainly depend on increased expression of
Pnc1, which is induced by CR [12]. Such a phenomenon
would seem to be required for Nam salvage to keep up
with increased Sir2 activity under CR conditions. How-
ever, because Nam levels are not reduced by CR, it is
not obvious how Nam clearance can be the driver of
increased Sir2 activity.
The NAD
+ metabolomic assay described in this study
should be empowering for multiple lines of investiga-
tion. This study, in addition to corroborating the exis-
tence of NAR and NR in cells grown without these
precursors [21], demonstrates that yeast cells maintain a
substantial proportion of potential NAD
+ equivalents in
two mononucleotide pools that can be driven forward to
produce NaAD and NAD
+ or driven backward by
dephosphorylation to produce NAR and NR. Such steps
in NAD
+ metabolism are almost certainly regulated by
novel mechanisms. Indeed, the quantitative analysis of
Table 5 Ratios of key metabolites: adenylyltransferase
subprofile
NaMN NaAD NAD
+ NMN
SDC -NA 0.01 N.D. 1.0 0.07
SDC 0.05 N.D. 1.0 0.13
YPD 0.03 0.009 1.0 0.14
YPD 0.5 0.06 N.D. 1.0 0.19
YPD 0.2 0.06 N.D. 1.0 0.21
Table 6 Ratios of key metabolites: nucleoside/nucleotide
subprofile
NAR NaMN NMN NR
SDC -NA 0.01 0.15 1.0 0.11
SDC 0.12 0.42 1.0 0.07
YPD 0.20 0.19 1.0 0.15
YPD 0.5 0.14 0.31 1.0 0.13
YPD 0.2 0.12 0.29 1.0 0.10
Evans et al. BMC Chemical Biology 2010, 10:2
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none of these precursors creates problems that will only
be solved by characterization of new genes, enzymes and
pathways. With knowledge of the gene set, ongoing stu-
dies are designed to determine the rates of flux of meta-
bolites upon imposition of CR and the nature of the
nuclear, mitochondrial and cytoplasmic NAD
+
metabolomes.
Methods
Materials
NR and NAR were synthesized as described [9]. All
other NAD
+ metabolites, nucleotides, nucleosides, 8-
aminooctanoic acid, ammonium acetate, glucose and
ammonium hydroxide were purchased from Sigma-
Aldrich Corp (St. Louis, MO). HPLC-grade water, aceto-
nitrile and methanol were purchased from Burdick and
Jackson (Muskegon, MI).
Saccharomyces cerevisiae strains, media and extraction
The analyzed yeast strain was BY4742 (MATa his3Δ1
leu2Δ0l y s 2 Δ0u r a 3 Δ0). The yeast strain grown in
13C
glucose was Fleischmann’s. Cells were grown in syn-
thetic dextrose complete (SDC) medium (1.7 g Difco
yeast nitrogen base without (NH4)2SO4 and without
amino acids), 5 g of (NH4)2SO4, 0.89 g amino acid mix
and 20 g dextrose per liter). SDC -NA contained 6.9 g
Formedium (Hunstanton, England) yeast nitrogen base
without amino acids and NA, 0.89 g amino acid mix,
and 20 g dextrose per liter. YPD contained 10 g yeast
extract, 20 g peptone and 20 g dextrose per liter.
Experimental cultures were grown overnight, diluted to
OD600 nm = 0.2, grown to mid-log phase (OD600 nm =
0.7-0.8), and collected by centrifugation. Pellets corre-
sponding to 25 ml of culture grown to mid-log phase
were collected and stored at -80°C prior to extraction in
0.3 ml of boiling, buffered ethanol (75% ethanol and
25% 10 mM HEPES adjusted to pH 7.1 with ammonium
hydroxide), drying by Speedvac, and resuspension in 0.1
ml of water [22]. Samples were then checked by absor-
bance at 260 nm, allowing the extracts from slightly
more dense cultures to be diluted to the same OD260 nm
as those from less dense cultures. Prior to LC-MS analy-
sis, samples were further diluted 4:1 with methanol to
give a final solvent composition of 80% methanol/20%
water in order to ensure adequate retention of the meta-
bolites of interest on the HILIC column. Total cell num-
ber as a function of cultural density was determined as
described [43]. Mol of a metabolite was converted to M
units using 7 × 10
-14 L as the intracellular volume of a
haploid yeast cell [23]. Though no corrections were
applied for potentially different and incomplete extrac-
tion efficiencies of the metabolites, every metabolite
tested, including NAD
+ and NADH, has an extraction
efficiency of 91% or greater [22]. All metabolite mea-
surements are reported as means from three indepen-
dent yeast cultures.
LC-MS
Chromatographic separation was performed using a
Waters Nanoacquity UPLC (Milford, MA). Separations
were based on hydrophilic interaction liquid chromato-
graphy (HILIC), similar to those that have been
described [44]. The 150 mm × 1.0 mm i.d. column con-
tained 3 μm Phenomenex Luna NH2 particles. The
mobile phases were acetonitrile (A) and 5 mM ammo-
nium acetate adjusted to pH 9.9 with ammonium hydro-
xide (B). Metabolites were separated with a linear
gradient (50 μl/min flow rate) from 30% to 100% (B)
over 15 min followed by a 5 min hold at 100% (B). The
mobile phase was returned to 30% (B) at 20.1 min and
the column was re-equilibrated for 10 min prior to the
next run. After completion of a day of runs, the column
was flushed with 30 column volumes of deionized water
and flushed with isopropanol for storage. MS/MS detec-
tion was carried out using a Micromass Quattro Ultima
tandem quadrupole MS operated in positive ion SRM
mode. The output of the LC column was coupled to the
MS using the heated ESI probe. Capillary voltage was
+3 kV. Desolvation gas and cone gas flow rates were
420 l/hr and 150 l/hr, respectively. The desolvation hea-
ter temperature was 350°C and the source was main-
tained at 140°C. SRM methods were optimized for each
compound by performing direct infusion of a 50 μM
standard solution in a solvent of 5 mM ammonium
acetate (pH 9.9) and acetonitrile (50:50 v/v) using a syr-
inge pump operated at 10 μl/min. SRM parameters for
quinolinic acid (QA), which could not be detected as a
positive ion, were optimized in negative ion mode using
a capillary voltage of -2.5 kV. Optimal MS/MS transi-
tions, cone voltages and collision energies are shown in
Table 1. LC-MS was performed using sequential moni-
toring of 17 SRM transitions (QA was excluded from
analyses of yeast samples). The dwell time for each tran-
sition was 100 ms, the inter-channel delay was 10 ms,
and the delay between scan cycles was 20 ms. The
resulting scan rate was one for each transition every
2.11 seconds. Automated peak detection and integration
were used to determine peak area and signal to noise
ratio. All peaks were visually inspected to ensure that
peaks were properly selected and appropriate bounds
were used. Calibration curves were generated using 2.5
μl injections of 0.05, 0.1, 0.3, 1, 3, 10, 30, and 100 μM
solutions of authentic standards in 80/20 methanol/
water. Weighted linear regressions (1/X) were used to
assess the linearity of the method and to calculate the
concentrations of metabolites in the yeast extract
samples.
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Page 8 of 10Additional file 1: Supplementary tables. Tables indicating observed
change of standard metabolite peak areas under extraction conditions
(Table S1) and ion suppression of standard metabolites in the presence
of
13C-labeled yeast extract (Table S2)
Click here for file
[http://www.biomedcentral.com/content/supplementary/1472-6769-10-2-
S1.DOC]
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